Eastman Chemical (NYSE:EMN) insider Damon Cary Warmack sold 4,417 shares of the firm’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $98.60, for a total value of $435,516.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Eastman Chemical (EMN) opened at $94.80 on Friday. Eastman Chemical has a 12 month low of $76.02 and a 12 month high of $104.08. The company has a market capitalization of $13,380.51, a price-to-earnings ratio of 9.37, a P/E/G ratio of 1.34 and a beta of 1.33. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.94 and a current ratio of 1.83.
Eastman Chemical (NYSE:EMN) last released its quarterly earnings results on Thursday, February 1st. The basic materials company reported $1.62 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.06 by $0.56. Eastman Chemical had a return on equity of 22.67% and a net margin of 15.44%. The firm had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.24 billion. During the same quarter last year, the business posted $1.51 EPS. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. analysts expect that Eastman Chemical will post 8.47 earnings per share for the current fiscal year.
Several research analysts have recently issued reports on the company. Zacks Investment Research raised Eastman Chemical from a “hold” rating to a “buy” rating and set a $109.00 price objective on the stock in a research note on Tuesday, January 9th. KeyCorp reaffirmed a “buy” rating and set a $118.00 price objective (up previously from $108.00) on shares of Eastman Chemical in a research note on Monday, January 8th. UBS Group raised their price objective on Eastman Chemical from $97.00 to $103.00 and gave the stock a “buy” rating in a research note on Friday, October 27th. Barclays raised their price objective on Eastman Chemical from $100.00 to $108.00 and gave the stock an “equal weight” rating in a research note on Monday, February 5th. Finally, Tudor Pickering assumed coverage on Eastman Chemical in a research note on Tuesday, November 14th. They set a “hold” rating on the stock. Nine investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $101.73.
WARNING: “Damon Cary Warmack Sells 4,417 Shares of Eastman Chemical (EMN) Stock” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://sportsperspectives.com/2018/02/10/damon-cary-warmack-sells-4417-shares-of-eastman-chemical-emn-stock.html.
About Eastman Chemical
Eastman Chemical Company (Eastman) is an advanced materials and specialty additives company. The Company’s segments include Additives & Functional Products (AFP), Advanced Materials (AM), Chemical Intermediates (CI), and Fibers. In the AFP segment, it manufactures chemicals for products in the coatings, tires, consumables, building and construction, industrial applications, including solar energy markets, animal nutrition, care chemicals, crop protection, and energy markets.
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.